THE 60 GY IN 3 TO 5 FRACTIONS RECOMMENDATION FOR STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR STAGE I NON-SMALL CELL LUNG CANCER (NSCLC) IS OVERKILL: A PLEA FOR A INDIVIDUALISED DOSE PRESCRIPTION

被引:0
|
作者
De Ruysscher, D. [1 ]
van Baardwijk, A. [2 ]
Tome, W. [3 ]
Bentzen, S. [3 ]
Wanders, S. [2 ]
Reymen, B. [2 ]
Borger, J. [2 ]
van Elmpt, W. [2 ]
Ollers, M. [2 ]
Lambin, P. [2 ]
机构
[1] MUCM, Maastricht, Netherlands
[2] MAASTRO Clin, Maastricht, Netherlands
[3] Univ Wisconsin, Sch Med & Publ H, Madison, WI USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1044
引用
收藏
页码:S356 / S357
页数:2
相关论文
共 50 条
  • [41] STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR OPERABLE STAGE I NON SMALL-CELL LUNG CANCER: CAN SBRT BE COMPARABLE TO SURGERY?
    Onishi, Hiroshi
    Shirato, Hiroki
    Nagata, Yasushi
    Hiraoka, Masahiro
    Fujino, Masaharu
    Gomi, Kotaro
    Karasawa, Katsuyuki
    Hayakawa, Kazushige
    Niibe, Yuzuru
    Takai, Yoshihiro
    Kimura, Tomoki
    Takeda, Atsuya
    Ouchi, Atsushi
    Hareyama, Masato
    Kokubo, Masaki
    Kozuka, Takuyo
    Arimoto, Takuro
    Hara, Ryusuke
    Itami, Jun
    Araki, Tsutomu
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1352 - 1358
  • [42] FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
    Hoopes, David J.
    Tann, Mark
    Fletcher, James W.
    Forquer, Jeffrey A.
    Lin, Pei-Fen
    Lo, Simon S.
    Timmerman, Robert D.
    McGarry, Ronald C.
    LUNG CANCER, 2007, 56 (02) : 229 - 234
  • [43] A comparison of stereotactic body radiation (SBRT) fractionation schedules for stage I non-small cell lung cancer (NSCLC): The Cleveland clinic experience
    Stephans, K. L.
    Djemil, T.
    Reddy, C. A.
    Videtic, G. M. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S38 - S39
  • [44] A phase I/II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
    Koto, M.
    Takai, Y.
    Ogawa, Y.
    Ariga, H.
    Takeda, K.
    Sakayauchi, T.
    Narasaki, K.
    Jingu, K.
    Yamada, S.
    EJC SUPPLEMENTS, 2007, 5 (04): : 380 - 380
  • [45] A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer
    Koto, Masashi
    Takai, Yoshihiro
    Ogawa, Yoshihiro
    Matsushita, Haruo
    Takeda, Ken
    Takahashi, Chiaki
    Britton, Keith R.
    Jingu, Kei-ichi
    Takai, Kenji
    Mitsuya, Masatoshi
    Nemoto, Kenji
    Yamada, Shogo
    RADIOTHERAPY AND ONCOLOGY, 2007, 85 (03) : 429 - 434
  • [46] Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
    Kim, Min-Jeong
    Yeo, Seung-Gu
    Kim, Eun Seok
    Min, Chul Kee
    Sean, Pyung
    ONCOLOGY LETTERS, 2013, 5 (03) : 840 - 844
  • [47] Stereotactic Body Radiotherapy for Stage I Non-small Cell Lung Cancer Causes Immune Suppression
    Maehata, Y.
    Onishi, H.
    Kuriyama, K.
    Aoki, S.
    Araya, M.
    Saito, R.
    Oguri, M.
    Marino, K.
    Komiyama, T.
    Araki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S624 - S624
  • [48] Diffusion of stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) in the Medicare population, 2007-2009.
    Yu, James B.
    Soulos, Pamela R.
    Cramer, Laura D.
    Decker, Roy H.
    Kim, Anthony W.
    Gross, Cary Philip
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
    Emilie Dubaere
    Mathilde Goffaux
    Marie Wanet
    Benoit Bihin
    Céline Gheldof
    Anne-Sophie Demoulin
    Antoine Bolly
    Frederique Bustin
    Fabrice Duplaquet
    Paul-Emile Baugnee
    Michel Gustin
    Vincent Hers
    Fabienne Maisin
    Eric Marchand
    Sebahat Ocak
    Lionel Pirard
    Oswald Vancutsem
    Evelyne Van Neck
    Guy Vandermoten
    Luminata Zaharia
    Vincent Remouchamps
    BMC Cancer, 19